摘要
目的:探讨血清CA125、EMAb联合测定诊断子宫腺肌病的临床价值。方法:经术后病理学检查确诊子宫腺肌病患者179例和子宫肌瘤患者129例,均手术前测定血清CA125水平和EMAb。结果;子宫腺肌病组血清CA125平均水平及EM-Ab阳性率均高于子宫肌瘤组,两组相比有显著差异性(P<0.001)及(P<0.01)。联合测定血清CA125水平和EMAb,以两项均阳性为诊断标准,诊断子宫腺肌病的敏感性为51.04%,特异性为100%。结论:测定血清CA125及EMAb对子宫腺肌病有明显的辅助诊断价值,联合测定有助于子宫肌瘤的鉴别,进一步提高诊断的正确性。
Objective: To discuss the clinical value of combined CA125 and EMAb in adenomysis. Methods: Examined serum CA125 concentration and EMAb expression in 179 adenomysis and 129 hysteromyoma patients. Results: Compared with hysteromyoma patients, the level of CA125 and the positive rat of EMAb in adenomysis were statistically raised (P 〈0.001, P 〈0.01) . Combined CA125 and EMAb , the sensitivity and specialty were 51.04% and 100% in adenomysis patients. Conclusion: It is greatly useful to combine CA 125 and EMAb in adenomysis patients.
出处
《中国妇幼保健》
CAS
北大核心
2007年第2期228-229,共2页
Maternal and Child Health Care of China